Last reviewed · How we verify
NCT03101917
Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE)
NA trial testing The Microtable® Stereotactic System in Hearing Loss, Cochlear in 12 participants. Not yet recruiting.
5 July 2028
Quick facts
| Lead sponsor | Medical University of South Carolina |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 1 July 2026 |
| Primary completion | 5 July 2028 |
| Estimated completion | 31 July 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- The Microtable® Stereotactic System
Conditions studied
- Hearing Loss, Cochlear — all drugs for Hearing Loss, Cochlear →
Sponsor
Medical University of South Carolina
Who can join
Adults 22 to 80, any sex, with Hearing Loss, Cochlear. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Microtable® Microstereotactic Frame and Drill Press and Associated Method for Cochlear Implantation consists of a patient-customized microstereotactic frame which targets the cochlea. The intended use of the device in this early feasibility study is to surgically access the cochlea, allowing placement of an intra-cochlear electrode array for cochlear implantation, thereby providing a less invasive surgical option than currently performed. Compared to traditional cochlear implantation (CI) surgery, the investigators hypothesize that the minimally invasive, image-guided approach may offer the following benefits: (1) shorter procedure time including shorter general anesthesia time, (2) less tissue removal potentially eliminating post-operative mastoid bone depression, decreased post-operative patient discomfort, and quicker wound healing, (3) better chance of preservation of taste secondary to preservation of the chorda tympani nerve, and (4) standardization of electrode placement potentially allowing more consistent placement within the scala tympani sub-compartment of the cochlea which has been shown to be associated with improved post-operative audiological performance. This early feasibility study will focus on the advantages of the new technology to the patient. Advantages to the healthcare delivery system will be examined during the pivotal study phase.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical Implementation of Second-generation Minimally Invasive Image-guided Cochlear Implantation Surgery.
Labadie RF, Riojas K, Von Wahlde K, Mitchell J, et al · · 2021 · cited 7× · PMID 33967246 · DOI 10.1097/mao.0000000000003025
Verify or expand the search:
- PubMed search for NCT03101917
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hearing Loss, Cochlear
Currently open trials in the same condition.
- NCT07287774 — Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids · NA · recruiting
- NCT06664697 — Post-Market Clinical Investigation of the IotaSOFT Insertion System · recruiting
Other Medical University of South Carolina trials
Trials by the same sponsor.
- NCT06491264 — Multiparameter Optimized tES for Memory in Aging · NA · withdrawn
- NCT07513389 — Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) · Phase 2 · not yet recruiting
- NCT07149207 — Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors · Phase 2 · recruiting
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07498257 — Adaptation and Randomized Controlled Trial of Written Exposure Therapy for Adolescents · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03101917 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of South Carolina
- Last refreshed: 5 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03101917.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing